SEP 27, 2019 8:37 AM PDT

AI Exponentially Accelerates Drug Development

WRITTEN BY: Annie Lennon

Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial intelligence technology however, this process is both becoming more cost-efficient and shorter, something that is expected to exponentially accelerate the development of new drugs. 

According to Brendan Frey, founder and CEO of AI-based drug discovery company, Deep Genomics, developing drugs has traditionally been like gambling, “It’s like the Big Pharma companies come into a casino, put a million-dollar coin into a slot machine and with some probability like 10% or something, they get a win (Robertson: 2019).”

This is where AI comes in. Until now, Deep Genomics has developed over 20 machine learning systems trained from both public and proprietary data to screen for disease-causing mutations while looking for drug targets. In just two hours, their technology can screen over 200,000 pathogenic mutations and automatically suggest potential drug targets.

Frey said, “I am certain that we are witnessing a new era of drug discovery… Our AI systems can figure out how diseases are caused and how to fix those diseases much more rapidly than humans ever could and also with a greater success rate (ibid.).”

In particular, Frey and his team have used their machine learning systems to find potential drugs for Wilson's disease, a rare genetic disorder that leads to excessive build-up of copper in various body tissues. If left untreated, it can cause liver disease and central nervous system dysfunction, ultimately leading to death (Rare Disease Database: 2019). Although current drugs m to reduce copper levels in the body by stopping their absorption from food, no treatments have yet been made to restore the body’s natural ability to remove the metal. 

Using Deep Genomics AI however, Frey and his team were both able to understand how a mutation changes an amino acid in a copper-binding protein, an identify 24 potential new drug candidates. After testing these further, they were then able to announce a candidate for further development as an investigational new drug (Philippidis: 2019). 

With such a process usually taking around 17 years now possible in just 18 months, Frederick Askari, the Director of the Wilson Disease Program at the University of Michigan said: ”The clarity that this artificial intelligence platform has brought to the scientific community is astounding and the potential of a therapy that could operate at the genomic level to correct the disease process is exciting.”


 

Sources

 

Roberston, Sally: News Medical 

Rare Disease Database: National Organization for Rare Disorders 

Philippidis, Alex: Genetic Engineering and Biotechnology News

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUN 10, 2020
Drug Discovery & Development
A Highly Targeted Cancer Therapeutic
JUN 10, 2020
A Highly Targeted Cancer Therapeutic
A study led by researchers at USC School of Pharmacy discusses a way to engineer drugs that highly target malignant tiss ...
JUN 24, 2020
Drug Discovery & Development
Gilead to Test Inhalable Remdesivir Against COVID-19
JUN 24, 2020
Gilead to Test Inhalable Remdesivir Against COVID-19
Gilead has announced that it will soon start trials for an inhalable form of Remdesivir, the first drug to receive Emerg ...
JUL 02, 2020
Cannabis Sciences
What is the Difference Between CBD and CBG?
JUL 02, 2020
What is the Difference Between CBD and CBG?
Like cannabidiol (CBD), cannabigerol (CBG) is a cannabinoid. Both compounds are found in cannabis plants. Both are also ...
JUL 05, 2020
Neuroscience
Iron Build-up in Brain Linked to Alzheimer's
JUL 05, 2020
Iron Build-up in Brain Linked to Alzheimer's
Researchers from the Medical University of Graz in Austria have found a link between the build-up of iron in the brain&# ...
JUL 19, 2020
Neuroscience
Eating Fish May Protect Brain from Air Pollution
JUL 19, 2020
Eating Fish May Protect Brain from Air Pollution
Researchers have found that a diet high in omega-3 fatty acids may prevent neurodegeneration among older women living in ...
JUL 19, 2020
Drug Discovery & Development
Nanodrug for Treating Invasive Breast Cancer
JUL 19, 2020
Nanodrug for Treating Invasive Breast Cancer
Scientists at the University of Arkansas created a nano-drug that may eradicate triple-negative breast cancer cells. Fin ...
Loading Comments...